LAWRENCE STINES: Open Payments
NPI 1306822978 · VICTORIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,956 in 118 payments from 22 companies in 2025. Trend: 2023 $2,445 · 2024 $2,862 · 2025 $2,956
Food & beverage: $2,956
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 23 | $417 |
| AstraZeneca Pharmaceuticals LP | 11 | $396 |
| Novo Nordisk Inc | 22 | $346 |
| Gilead Sciences, Inc. | 3 | $280 |
| Lilly USA, LLC | 7 | $277 |
| GlaxoSmithKline, LLC. | 11 | $250 |
| Corcept Therapeutics | 5 | $211 |
| Axsome Therapeutics, Inc. | 5 | $162 |
| Xeris Pharmaceuticals, Inc. | 6 | $117 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $96 |
Products named: NURTEC ODT, FARXIGA, TRELEGY ELLIPTA, Korlym, MOUNJARO, Ozempic, Auvelity, JARDIANCE.
Industry payments across TX — which companies pay providers there.
